US Dollar vs Yen

登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Vor Biopharma Inc (VOR)
Vor Biopharma Inc (VOR) ニュース

VOR

Vor Biopharma (VOR)

Vor Biopharma Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:VOR

1 2 3 4 5 6 7 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/12/09	21 : 39	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VOR	Vor Biopharma Inc
2024/12/09	21 : 30	GlobeNewswire Inc.	Vor Bio Provides Clinical Update Further Validating Approach of Using Shielded Transplants to Deliver Targeted Therapies; Receives Supportive Feedback from FDA Regarding Registrational Trial Design	NASDAQ:VOR	Vor Biopharma Inc
2024/11/15	06 : 33	Edgar (US Regulatory)	Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:VOR	Vor Biopharma Inc
2024/11/12	22 : 00	GlobeNewswire Inc.	Vor Bio to Participate in the Stifel 2024 Healthcare Conference	NASDAQ:VOR	Vor Biopharma Inc
2024/11/09	06 : 20	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VOR	Vor Biopharma Inc
2024/11/09	06 : 15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VOR	Vor Biopharma Inc
2024/11/08	06 : 05	GlobeNewswire Inc.	Vor Bio Reports Third Quarter 2024 Financial Results and Provides Company Update	NASDAQ:VOR	Vor Biopharma Inc
2024/11/08	06 : 01	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:VOR	Vor Biopharma Inc
2024/11/06	06 : 15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VOR	Vor Biopharma Inc
2024/11/06	06 : 15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VOR	Vor Biopharma Inc
2024/10/03	05 : 17	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VOR	Vor Biopharma Inc
2024/10/03	05 : 16	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:VOR	Vor Biopharma Inc
2024/09/30	20 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VOR	Vor Biopharma Inc
2024/09/30	20 : 00	GlobeNewswire Inc.	Vor Bio Appoints Seasoned Healthcare Institutional Investor, Han Choi, M.D., LL.M., as Chief Financial Officer	NASDAQ:VOR	Vor Biopharma Inc
2024/09/06	05 : 06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VOR	Vor Biopharma Inc
2024/09/06	05 : 01	GlobeNewswire Inc.	New Clinical Data Validates Vor Bio’s Approach of Using Shielded Transplants to Deliver Targeted Therapies	NASDAQ:VOR	Vor Biopharma Inc
2024/09/05	05 : 15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VOR	Vor Biopharma Inc
2024/09/05	05 : 15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VOR	Vor Biopharma Inc
2024/08/31	05 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VOR	Vor Biopharma Inc
2024/08/28	21 : 00	GlobeNewswire Inc.	Vor Bio to Participate in Upcoming Investor Conferences	NASDAQ:VOR	Vor Biopharma Inc
2024/08/09	05 : 29	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VOR	Vor Biopharma Inc
2024/08/09	05 : 13	Edgar (US Regulatory)	Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]	NASDAQ:VOR	Vor Biopharma Inc
2024/08/09	05 : 05	GlobeNewswire Inc.	Vor Bio Reports Second Quarter 2024 Financial Results and Provides Company Update	NASDAQ:VOR	Vor Biopharma Inc
2024/08/09	05 : 01	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:VOR	Vor Biopharma Inc
2024/08/06	05 : 15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VOR	Vor Biopharma Inc
2024/08/03	05 : 01	GlobeNewswire Inc.	Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:VOR	Vor Biopharma Inc
2024/07/20	06 : 04	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:VOR	Vor Biopharma Inc
2024/07/10	05 : 01	GlobeNewswire Inc.	Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:VOR	Vor Biopharma Inc
2024/06/11	05 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VOR	Vor Biopharma Inc
2024/06/05	05 : 01	GlobeNewswire Inc.	Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:VOR	Vor Biopharma Inc

Showing the most relevant articles for your search:NASDAQ:VOR

1 2 3 4 5 6 7 次へ >>

US Dollar vs Euro

Deutsche Telekom (QX)

Invesco QQQ Trust Series 1

Verizon Communications

Health Care Select Sector

Gold vs US Dollar

Energy Select Sector SPDR

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約